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Edited by Lukas HuberAbstract Rab coupling protein (RCP) is a member of the
Rab11-family of interacting proteins (Rab11-FIPs). Family
members are characterised by their ability to interact with
Rab11. This property is mediated by a conserved Rab binding
domain (RBD) located at their carboxy-termini. Several Rab11-
FIPs can also interact with other small GTPases. RCP interacts
with Rab4 in addition to Rab11. To dissect out the individual
properties of the Rab4 and Rab11 interactions with RCP,
conserved amino acids within the RBD of RCP were mutated by
site-directed mutagenesis. The eﬀect of these mutations on Rab4
and Rab11 binding, and the intracellular localisation of RCP,
was examined. Our results indicate that Rab11, rather than
Rab4, mediates the intracellular localisation of RCP, and that
the class I Rab11-FIPs compete for binding to Rab11.
 2004 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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compartmentRCP(Y620F) Sense 50-GTCCGCGAGCTGGAAGACTTCATTG-
ACAACCTGCTTGTC-30
RCP(Y620F) Anti 50-GACAAGCAGGTTGTCAATGAAGTCT-
TCAGCTCGCGGAC-30
RCP(I621E) Sense 50-CGCGAGCTGGAAGACTACGAGGAC-
AACCTGCTTGTCAGG-30
RCP(I621E) Anti 50-CCTGACAAGCAGGTTGTCCTCGTAG-1. Introduction
Rab coupling protein (RCP) is a member of the recently
identiﬁed Rab11-family of interacting proteins (Rab11-FIP)
family, a family of proteins that are characterised by their
ability to bind the small GTPase Rab11. The members of this
family can be divided into two classes, the class I Rab11-FIPs
possess homologous C2 domains near their amino-termini and
the class II Rab11-FIPs possess an ERM-like domain and a
proline rich domain. However, they all share a highly homol-
ogous Rab binding domain (RBD) at their carboxy-termini,
through which they interact with Rab11 [1–4]. The class I
Rab11-FIPs, to which RCP belongs, localise to the endocytic
recycling compartment (ERC) where they function to regulate
traﬃc from the ERC to the plasma membrane. A number of
the Rab11-FIPs can also interact with other small GTPases.
Rab11-FIP3 and Rab11-FIP4 (also known as arfophilin-1 and
arfophilin-2, respectively) interact with Arf4, Arf5 and Arf6
[5–7]. RCP binds to the active conformation of Rab4, in ad-* Corresponding author. Fax: +353-21-4901379.
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doi:10.1016/j.febslet.2004.06.068dition to interacting with Rab11 [4]. The ability of RCP to
bind to Rab4 is unique among the Rab11-FIPs and led us to
propose that RCP serves as a ‘molecular-link’ between Rab4-
regulated transport from the sorting endosome (SE) and
Rab11-regulated transport from the ERC. Rabaptin-5 and
Rabenosyn-5 have recently been described as divalent Rab
eﬀectors [8,9], in that they can both bind simultaneously to
Rab5 and Rab4, thus serving as a link between Rab5- and
Rab4-regulated membrane traﬃc. The Rab5 and Rab4 bind-
ing domains on these two eﬀectors are located at diﬀerent re-
gions of the protein. In contrast, we have narrowed the Rab4
and Rab11 binding domains of RCP to the same 65 amino
acids at the carboxy-terminus [4]. In order to help deﬁne the
roles of the Rab4 and Rab11 interactions individually, we
made a series of point mutations at key residues in its putative
RBD. Using this method we have generated an RCP mutant
that has the ability to bind Rab11 but not Rab4, and a mutant
in which both Rab4 and Rab11 binding is abolished. We have
transiently expressed these mutants in mammalian cells and
show here that Rab11 recruits RCP to the recycling com-
partment. Furthermore, we demonstrate that the class I
Rab11-FIPs compete with each other for binding to Rab11.2. Materials and methods
2.1. Plasmids and site-directed mutagenesis
The Rab4 and Rab11 yeast two-hybrid constructs, pEGFP-C3 RCP,
pEGFP-C1 Rab4, and pEGFP-C1 Rab11-FIP3 constructs, have been
described elsewhere [4,10–12]. Site-directed mutagenesis was per-
formed using the QuikChange kit (Stratagene) according to the man-
ufacturer’s instructions. GFP-RCP or GFP-Rip11 was used as
template and the following sense and antisense oligonucleotides were
used (codon changes are indicated in bold).TCTTCCAGCTCGCG-30
RCP(D622N) Sense 50-GCTGGAAGACTACATTAACAACCTG-
CTTGTCAGGG-30
RCP(D622N) Anti 50-CCCTGACAAGCAGGTTGTTAATGTA-
GTCTTCCAGC-30
Rip11(I630E) Sense 50-CAGGAGCTGGAGAGCTACGAGGAC-
CGGCTGCTGGTGCGG-30
Rip11(I630E) Anti 50-CCGCACCAGCAGCCGGTCCTCGTA-
GCTCTCCAGCTCCTG-30
blished by Elsevier B.V. All rights reserved.
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The cDNA for each of the RCP mutants was subcloned from the
BamHI site of pEGFP-C3 into the BamHI site of the pGADGH yeast
two-hybrid vector. To generate the bacterial expression vectors, the
RCP mutants were subcloned into the BamHI and EcoRI sites of
pTrcHisB (Invitrogen) from pEGFP-C3.2.2. Biochemical interactions
Escherichia coli lysates expressing RCP(WT) and mutants were
separated by SDS–PAGE and transferred to nitrocellulose. The ni-
trocellulose was blocked overnight in Basic buﬀer (BB: 20 mM
HEPES, pH 7.5; 50 mM KCl, 10 mM MgCl2, 1 mM DTT, and 0.1%
NP-40) plus 5% non-fat dried milk. Meanwhile, 10 lg of the GST-
Rab fusion proteins was loaded with GTPcS by incubation in
20 mM HEPES, pH 7.5; 4 mM EDTA; and 100 lM GTPcS at 37 C
for 30 min. MgCl2 was subsequently added to a ﬁnal concentration
of 10 mM. The fusion proteins were then overlayed onto the ni-
trocellulose in interaction buﬀer (BB plus 1% non-fat dried milk) and
rocked at 4 C for 4 h. The nitrocellulose was then washed with
TBS–T (10 mM Tris, pH 7.5; 150 mM NaCl; and 0.1% Tween 20).
Bound GST-Rab11 or Rab4 was revealed with an anti-GST anti-
body (Sigma).2.3. Cell culture and immunoﬂuorescence
HeLa and A431 cells were maintained in culture in DMEM (Bio-
Whittaker) supplemented with 10% foetal bovine serum, 100 units/ml
penicillin, 100 lg/ml streptomycin, and 2 mM glutamine. For immu-
noﬂuorescence, cells were seeded onto 10 mm glass coverslips. Trans-
fections were performed using Eﬀectene (Qiagen) according to the
manufacturer’s instructions. Approximately 16 h post-transfection the
cells were ﬁxed with 3% paraformaldehyde, quenched with 50 mM
NH4Cl, and permeabilised in 0.05% saponin/0.2% BSA. The ﬁxed cells
were either labelled with anti-RCP (1:150) [4] or anti-Rab11 (1:250)
[11]. Texas red-labelled donkey anti-rabbit (Jackson Immunochemi-
cals) was used as secondary antibody. Images were acquired on a Zeiss
LSM 510 confocal microscope using a PlanApo 63X 1.4 NA oil im-
mersion objective and processed using Image Examiner software (Carl
Zeiss).2.4. Miscellaneous protocols
The yeast two-hybrid experiments were performed as previously
described [4]. To prepare membrane and cytosol fractions, HeLa cells
expressing the GFP-RCP constructs were resuspended in fractionation
buﬀer (FB: 50 mM Tris, pH 7.4, 250 mM sucrose, and 1 mM EDTA)
and lysed by freeze-thawing and passage through a 26 gauge needle. A
post-nuclear supernatant was generated by centrifugation at 5000· g.
The PNS was then spun at 200 000· g for 30 min at 4 C in an MLA-
130 rotor (Beckman). The high-speed supernatant (cytosol) was re-
moved and the high-speed pellet (membrane) was resuspended in an
equal volume of FB. The same volumes of each fraction were sepa-
rated on an SDS–PAGE gel, transferred to nitrocellulose and probed
with anti-GFP (Abcam). The fractionation procedure was con-
trolled by probing the blot with anti-TfnR (Zymed) and anti-b tubulin
(Sigma).3. Results
3.1. Generation of RCP Rab binding domain mutants
Multiple alignment of the carboxy-terminal region of each
member of the Rab11-FIPs reveals a domain of approxi-
mately 20 residues that shows a high degree of sequence
conservation (Fig. 1A) [3]. As this region has already been
shown to mediate the interaction of Rip11 and Rab11-FIP3
with Rab11, we wished to investigate its importance in RCP
binding to Rab4 and Rab11 [3]. Structural analysis of this 20
amino acid domain of RCP reveals that it has the potential to
form an amphipathic helix (Fig. 1B). In order to establish if
this region is responsible for binding to Rab11 and/or Rab4,the tyrosine, isoleucine, and aspartic acid residues at positions
620, 621, and 622, respectively, were individually mutated.
We used the yeast two-hybrid system to test for the ability of
these mutants to interact with the two Rab GTPases, and also
for their ability to self-interact, since RCP has been shown to
homodimerise [13] (Fig. 1C). The RCP(Y620F) mutant re-
tains the ability to bind Rab11 and to dimerise, but displays
weaker Rab4 binding. In contrast, an isoleucine to glutamic
acid change at position 621, (RCP(I621E)), results in the
complete abolition of Rab4 and Rab11 binding, and also the
ability to dimerise. The aspartic acid to asparagine mutation
at amino acid 622 generates a mutant that can bind eﬃciently
to Rab11 and to itself, but not to Rab4. Western blotting of
yeast lysates, that are expressing the RCP mutants, conﬁrms
that the wild-type and mutant proteins are expressed at
similar levels and that the abolition of an interaction with
Rab4 and Rab11 is not due to instability of the RCP(I621E)
mutant (data not shown). To conﬁrm the yeast two-hybrid
data biochemically, a Far Western approach was adopted.
Bacterial lysates expressing wild-type RCP and the three RCP
mutants were transferred to nitrocellulose and overlayed with
10 lg of puriﬁed GST-Rab4 or GST-Rab11 that had been
preloaded with GTPcS (see Section 2). Rab protein bound to
RCP was detected with an anti-GST antibody (Fig. 1D).
GST-Rab11 displayed a strong interaction with RCP(WT)
and slightly weaker interactions with RCP(Y620F) and
RCP(D622N), but no interaction with the I621E mutant.
GST-Rab4 interacted with RCP(WT) and RCP(Y620F) but
did not interact with either RCP(I621E) or RCP(D622N).
Hence, the biochemical interactions fully support the two-
hybrid data. It should be noted that the mobility of the RCP
mutants on an SDS–PAGE gel is slightly altered, possibly
due to an eﬀect of the mutations on the RCP secondary
structure.
Thus, the conserved 20 amino acids at the carboxy-terminus
of RCP, which are likely to form an a-helix, mediate its in-
teraction with both Rab4 and Rab11. This region is also re-
sponsible for the ability of RCP to dimerise. Since this binding
motif is relatively small, and a single point mutation can
abolish all three interactions, it is unlikely that both Rab4 and
Rab11 can bind simultaneously to an individual RCP mole-
cule. It is possible that the two small GTPases may compete
for binding to RCP and this binding may depend on the ac-
tivation state of RCP or on its intracellular localisation. Al-
ternatively, the formation of an RCP dimer or higher order
oligomer in vivo could provide a means whereby Rab4 and
Rab11 could bind simultaneously to the same complex. Since
the RCP(I621E) mutant does not dimerise, it is possible that
dimerisation of RCP is an essential requirement for Rab
binding.
3.2. Intracellular localisation of RCP and mutants
Wild-type RCP localises to the ERC, and we have recently
demonstrated that treatment of cells with the epidermal
growth factor (EGF), or phorbol 12-myristate 13-acetate, can
induce its translocation from the ERC to the plasma mem-
brane [11]. To determine the eﬀect of the RBD mutations on
the intracellular localisation of RCP, each mutant was fused
to the C-terminus of the green ﬂuorescent protein (GFP) and
expressed in mammalian cells (Fig. 2A). As expected, wild-
type GFP-RCP displayed a vesicular punctate pattern
when expressed in HeLa cells. GFP-RCP(Y620F) and
Fig. 1. Analysis of the Rab binding domain (RBD) of RCP. (A) ClustalW alignment of the carboxy-terminal regions of the Rab11-FIP family, with
the RBD indicated [3]. The red box denotes the amino acids that were mutated. (B) Residues 616–633 of RCP have the potential to form an am-
phipathic a-helix (http://cti.itc.virginia.edu/~cmg/Demo/wheel/wheelApp.html). (C) Yeast two-hybrid analysis of the RCP mutants. Gal4 activation
domain fusion constructs of RCP(WT), and mutants, were co-transformed into the L40 strain of S. cerevisiae with binding domain fusions of
constitutively active Rab11 and Rab4, or with the carboxy-terminal region of RCP. Transformant colonies were spotted onto media lacking histidine
(His)). An interaction is indicated by growth on the His) media. (D) Biochemical analysis of the Rab binding properties of wild-type RCP and
mutants. E. coli lysates expressing His-RCP(WT) and mutants were separated by SDS–PAGE and transferred to nitrocellulose. The nitrocellulose
was overlayed with GTPcS loaded GST-Rab11 or Rab4. Bound Rab protein was identiﬁed by blotting with anti-GST (top and middle panels).
Loading of RCP fusion proteins was revealed by blotting with anti-RCP (bottom panel).
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the wild-type protein. However, the GFP-RCP(I621E) fusion
protein was completely cytosolic and did not localise to
any vesicular structures. In some cases, with the I621E mu-
tant some labelling of ruﬄes in the plasma membrane was
observed. This localisation is likely to be mediated via the
amino-terminal C2 domain [11]. To conﬁrm the immuno-
ﬂuorescence results biochemically, HeLa cells expressing each
of the GFP-fusion constructs were fractionated into a high-
speed supernatant (cytosol) and high-speed pellet (mem-
brane). Western blots of these fractions, normalised to cell
volume, were then probed with an anti-GFP antibody
(Fig. 2B). The GFP-RCP(WT), GFP-RCP(Y620F), and
GFP-RCP(D622N) recombinant proteins were found in both
the cytosol and membrane fractions. However, GFP-
RCP(I621E) was found exclusively in the cytosolic fraction.
These results verify our immunoﬂuorescence data.
In summary, RCP(D622N) can bind Rab11 but not Rab4,
whereas RCP(I621E) can bind neither Rab11 nor Rab4. Since
RCP(D622N) can bind membranes and displays a vesicular
pattern very similar to that of the wild-type protein, it can be
concluded that Rab4 is not required for the correct intracel-
lular localisation of RCP. Furthermore, the observation that
RCP(I621E) is a cytosolic protein suggests that RCP locali-
sation is mediated by Rab11. Thus, Rab11 is a likely candi-
date mediator of RCP recruitment onto the ERC membrane.
This is consistent with our data indicating that there is very
little RCP localised to the sorting endosome [4], the com-
partment where the majority of Rab4 resides, and ﬁts with
our model that RCP may serve as a recycling compartment
target for Rab4-regulated transport vesicles originating from
the SE.
3.3. Rab11 expression can alter RCP localisation
To further investigate if membrane-bound Rab11 recruits
RCP to the ERC, we assessed the pattern of endogenousFig. 2. The RCP/Rab11 interaction is required for RCP membrane associati
with paraformaldehyde and analysed by confocal microscopy. (B) HeLa cells
supernatant (C) and high-speed membrane pellet (M). Cytosol and membrane
transferred to nitrocellulose. Blots were probed with anti-GFP to detect th
fractionation controls. Bar, 10 lm.Rab11 or RCP in cells expressing various mutant constructs.
Thus, GFP-RCP wild-type and mutant constructs were
transfected into the A431 epidermal carcinoma cell line. Six-
teen hours post-transfection, the cells were ﬁxed and labelled
for endogenous Rab11 (Fig. 3A). The Rab11 pattern did not
diﬀer signiﬁcantly in cells expressing the diﬀerent mutants, or
from the pattern observed in non-transfected cells. The ob-
servation that Rab11 localisation was unaﬀected in cells ex-
pressing RCP(I621E), the Rab11-binding defective mutant is
consistent with the hypothesis that Rab11 membrane binding
is not dependent on RCP. In contrast, the expression of a
dominant negative Rab11(S25N) mutant resulted in the re-
distribution of RCP to the cytoplasm (Fig. 3B). Rab11(S25N)
is locked in the GDP-bound inactive conformation and is
predominantly cytosolic [14]. Our yeast two-hybrid data sug-
gest that RCP can bind to Rab11(S25N) indicating that, when
expressed in cells, the mutant binds to RCP preventing it from
interacting with endogenous Rab11 at the ERC. RCP displays
a normal vesicular pattern in cells expressing wild-type Rab11
and constitutively active Rab11(Q70L). Rab4 or its mutants
have no eﬀect on endogenous RCP recycling compartment
localisation (Fig. 3C).
3.4. The class I Rab11-FIPs compete for binding to Rab11
To investigate if the Rab11-FIPs compete for binding to
Rab11, the localisation of endogenous RCP was examined in
cells expressing GFP-fusions of the class I member Rip11, or
the class II Rab11-FIP3 (Fig. 4). In cells expressing GFP-
Rip11, the fusion protein has a normal vesicular pattern,
whereas endogenous RCP displays a reduced membrane lo-
calisation when compared to non-transfected cells. Expression
of GFP-Rab11 FIP3 results in the formation of an enlarged
tubulo-vesicular structure to which RCP is found to colocalise
with Rab11-FIP3. These results indicate that the class I
Rab11-FIPs, but not the class II family members, compete for
binding to Rab11. Overexpression of Rip11 results in theon. (A) HeLa cells transfected with the indicated construct were ﬁxed
expressing the indicated constructs were fractionated into a high-speed
fractions, normalised to cell volume, were resolved by SDS–PAGE and
e RCP fusion proteins. Anti-TfnR and anti-b tubulin were used as
Fig. 3. Rab11 mediates RCP binding to the ERC. (A) A431 cells expressing the indicated GFP-fusion protein were ﬁxed with paraformaldehyde,
permeabilised with saponin, and labelled for endogenous Rab11. (B) The indicated Rab11 GFP-fusion constructs were transfected into A431 cells. 16
h post-transfection the cells were ﬁxed, permeabilised, and labelled for endogenous RCP. (C) The indicated Rab4 GFP-fusion constructs were
transfected into A431 cells. 16 h post-transfection the cells were ﬁxed, permeabilised, and labelled for endogenous RCP. Transfected cells are in-
dicated with an asterisk. Bar, 10 lm.
90 A.J. Lindsay, M.W. McCaﬀrey / FEBS Letters 571 (2004) 86–92
Fig. 4. Class I Rab11-FIP members compete in vivo for binding to Rab11. The indicated Rab11-FIP GFP-fusion constructs were transfected into
A431 cells. 16 h post-transfection the cells were ﬁxed, permeabilised, and labelled for endogenous RCP. Transfected cells are indicated with an
asterisk. Bar, 10 lm.
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creased cytoplasmic localisation. In contrast, expression of
Rab11-FIP3 does not inhibit the membrane localisation of
endogenous RCP, suggesting that the class II Rab11-FIPs
employ another mechanism for their membrane localisation.
This mechanism may involve the ARF GTPases to which they
have been shown to bind [6,7], or may involve an as yet un-
identiﬁed recruitment mechanism. To further conﬁrm that the
class I Rab11-FIPs compete for Rab11 binding, we made use
of a Rip11 mutation, Rip11(I630E), which has been shown to
abolish its Rab11 binding [15]. In cells expressing GFP-
Rip11(I630E), the normal vesicular pattern of RCP is restored,
demonstrating that the cytoplasmic localisation of RCP in
GFP-Rip11 expressing cells is due to Rip11 sequestration of
Rab11.4. Discussion
We have used site-directed mutagenesis to assess the sig-
niﬁcance of the Rab4 and Rab11 binding properties of
RCP. We investigated the importance of a conserved region
at the carboxy-terminus of RCP that we believe mediates its
Rab binding ability. By mutating individual amino acids in
this region, we have generated an RCP mutant in which
Rab GTPase binding is abolished and a mutant which can
bind Rab11 but not Rab4. The mutant with aberrant Rab4,
but normal Rab11 binding, displays a typical wild-type in-
tracellular localisation when expressed as a GFP-fusion in
mammalian cells. In contrast, the RCP(I621E) mutant
which can bind neither Rab4 nor Rab11 is completely cy-
toplasmic. Fractionation studies of cells expressing each
mutant yield similar results, in that the RCP(I621E) fusion
protein partitions exclusively in the cytosolic fraction,
whereas the wild-type protein and all mutants that maintain
the ability to bind Rab11 are also detected in the membrane
fraction.RCP is localised to the ERC and the mutagenesis results
suggest that Rab11, rather than Rab4, mediates this local-
isation. This hypothesis is further borne out by the obser-
vation that the expression of dominant-negative or
dominant-active mutants of Rab4 does not perturb RCP
intracellular localisation. However, expression of a domi-
nant-negative mutant of Rab11, Rab11(S25N), results in the
redistribution of endogenous RCP to the cytoplasm. Ex-
pression of the RCP mutants does not aﬀect the localisation
of Rab11. A perturbation of endogenous Rab11 localisation
would be expected if RCP binding to the ERC preceded
Rab11 binding. We also demonstrate that the class I
Rab11-FIPs, but not the class II Rab11-FIPs, compete with
each other for binding to Rab11. Overexpression of Rip11
results in the redistribution of RCP to the cytoplasm,
consistent with a model in which the overexpressed protein
out-competes RCP for binding to Rab11. In contrast, when
Rab11-FIP3 is transiently overexpressed it forms a large
tubulo-vesicular structure that is positive for RCP. Taken
together, these data suggest that the class II Rab11-FIPs
may have an alternative mechanism for binding vesicular
membranes.
The data presented in this paper are consistent with a model
in which Rab11 recruits cytosolic RCP to the ERC, where it
can then act as a target for Rab4-regulated transport vesicles
en route from the sorting endosome.Acknowledgements: We are grateful to the members of the Molecular
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